Company news

Harrow, Inc. news in 2021

Harrow, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops

December 19, 2021

Harrow Health Added to the Nasdaq Biotechnology Index

December 12, 2021

EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce Expanded U.S. Commercial Alliance for DEXYCU®

December 6, 2021

Harrow Health Announces Third Quarter 2021 Financial Results

November 8, 2021

Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021

October 24, 2021

Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals

September 1, 2021

Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.

August 17, 2021

Harrow Health to Participate in Two Upcoming Virtual Investor Conferences

August 11, 2021

Harrow Health Announces Second Quarter 2021 Financial Results

August 9, 2021

Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica

July 26, 2021

Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021

July 25, 2021

NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova

July 18, 2021

Harrow Health Granted Two Patents for Novel Surgical Dilation Formulation

July 14, 2021

Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 16, 2021

Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 13, 2021

Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones

June 13, 2021

Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology

June 2, 2021

Harrow Health Launches New Corporate and Investor Website

May 31, 2021

Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops

May 16, 2021

Harrow Health Announces Record First Quarter 2021 Financial Results

May 10, 2021

Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock

May 4, 2021

Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes

May 4, 2021

Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021

April 26, 2021

Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026

April 19, 2021

Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026

April 14, 2021

Harrow Health Announces Preliminary First Quarter 2021 Financial Results

April 13, 2021

Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones

April 13, 2021

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

March 7, 2021

Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference

March 1, 2021

Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021

February 24, 2021

Calls in 2021

Decks in 2021